Template:Immunohistochemistry evaluation of invasive breast cancer

From patholines.org
Jump to navigation Jump to search

Immunohistochemistry

  • Ki-67 index:[1]
Ki-67 in an invasive breast cancer: cancer nuclei are stained (brown). There is tumor cell positivity in 70% of the cells (Ki-67 labelling index = 70%).
  • At least three high-power (×40 objective) fields should be selected
  • At least 500 malignant invasive cells should be counted, unless a protocol clearly states reasons for fewer being acceptable.
  • The invasive edge of the tumor should be scored
  • If a comparisons must be made between core biopsies and sections from an excision, evaluation of the latter should be across the whole tumor.
  • Only nuclear staining counts. Staining intensity of a positive nucleus is not relevant.
  • HER2/neu score or status:
Score[2] Status[2]
0 to 1+ HER2 negative
(not present)
2+ Borderline
3+ HER2 positive

Notes


Main page

References

  1. Dowsett, M.; Nielsen, T. O.; A'Hern, R.; Bartlett, J.; Coombes, R. C.; Cuzick, J.; Ellis, M.; Henry, N. L.; et al. (2011). "Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group ". JNCI Journal of the National Cancer Institute 103 (22): 1656–1664. doi:10.1093/jnci/djr393. ISSN 0027-8874. 
  2. 2.0 2.1 . IHC Tests (ImmunoHistoChemistry). Breastcancer.org. Retrieved on 2019-10-04. Last modified on October 23, 2015

Image sources